Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of May 13, 2025 • 9:01 PM ET

Date/Time Source News Release
12/12/2022 12:18 AM EST Business Wire Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286
10/27/2022 05:05 PM EDT Business Wire Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific Retreat
10/17/2022 03:45 AM EDT Business Wire Clovis Oncology Highlights Updated LuMIERE Phase 1 Data of Targeted Radiotherapy Candidate FAP-2286 at the 35th Annual EANM Congress
10/03/2022 07:00 AM EDT Business Wire TRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM Mutations
09/21/2022 08:00 AM EDT Business Wire Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement
09/13/2022 08:00 AM EDT Business Wire Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian Cancer
09/11/2022 10:30 AM EDT Business Wire Clovis Oncology's Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups
08/08/2022 08:00 AM EDT Business Wire Clovis Oncology Announces Second Quarter 2022 Operating Results and Provides Update on Clinical Development Programs
07/20/2022 06:06 PM EDT Business Wire CORRECTING and REPLACING Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8
07/20/2022 04:00 PM EDT Business Wire Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8
Page

Additional News

As of May 13, 2025 • 9:01 PM ET

Date/Time Source News Release
12/21/2022 09:39 AM EST Zacks Bet on 5 Top Stocks With Rising P/E
12/12/2022 10:38 AM EST Zacks Clovis (CLVS) Files for Bankruptcy Amid Lack of Financial Aid
12/12/2022 10:26 AM EST InvestorPlace CLVS Stock Alert: What to Know as Clovis Oncology Files for Bankruptcy
12/12/2022 06:38 AM EST SeekingAlpha Clovis stock slumps amid Chapter 11 filing, to sell FAP-2286 to Novartis for $50M upfront
12/09/2022 11:30 AM EST Zacks Clovis (CLVS) Down 18.1% Since Last Earnings Report: Can It Rebound?
12/05/2022 01:19 PM EST InvestorPlace Why Is Bed Bath & Beyond (BBBY) Stock Down 75% in 2022?
12/05/2022 01:04 PM EST InvestorPlace Why Is Top Ships (TOPS) Stock Down 59% Today?
12/05/2022 12:44 PM EST InvestorPlace Dear CLVS Stock Fans, Get Ready for a Bankruptcy Filing
11/25/2022 12:34 PM EST Zacks Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why
11/21/2022 09:35 AM EST Zacks Down 67.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Clovis (CLVS)
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.